Essential Hypertension
📧 Sign up to get email alerts when something new happens for Essential Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-08-20FDA Approved: LISINOPRIL — Original Application (ANNORA PHARMA)
FDA approval overview for lisinopril original application by Annora Pharma.
-
EMA approval · 2026-07-14EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
EMA has authorized Qaialdo, a spironolactone product by Lipomed GmbH, for several conditions including edema, heart failure, liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS [Phase 3]
Phase III trial evaluating AGSAVI for essential hypertension inadequately controlled with AGLS has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating monotherapy HL1113R1 or HL1113R2 versus fixed-dose combination in essential hypertension with type 2 diabetes; curr…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension [Phase 1]
An early Phase 1 study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of ADX-850 in participants with hypertensio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT [NA]
A clinical trial evaluating a bradycardia pacemaker with AV interval modulation for hypertension is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Vascular Impact of Omega-3 in Metabolic Syndrome [NA]
A clinical trial evaluating the vascular effects of omega-3 fatty acids in individuals with metabolic syndrome and essential hypertension ha…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: The Use of Virtual Reality and Music Therapy for Hypertensive Urgency [NA]
A completed clinical trial investigating the effects of virtual reality and music therapy on hypertensive urgency and essential hypertension…
-
EMA approval · 2026-03-24EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
Qaialdo is a spironolactone product by Lipomed GmbH that has been authorized in the EU. Indications include edema, heart failure, liver cirr…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income [NA]
A clinical trial registry entry for a study to improve prenatal care to reduce early onset preeclampsia in low-income populations; status is…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Personalised Dose Optimisation of Zestril Supported by the Digital Blood Pressure Diary in a Primary Care Environment in England: Pragmatic Observational Pilot Study for Remote Hypertension Treatment
A pragmatic observational pilot study evaluating personalised dose optimisation of lisinopril (Zestril) using a digital blood pressure diary…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension [Phase 3]
A Phase III study evaluating the efficacy and safety of DWC202405, DWC202313, and DWC202314 in adults with essential hypertension has comple…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension [Phase 1]
An early-phase study (Phase 1) evaluating KK3910 in healthy volunteers and patients with essential hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease [NA]
This clinical trial update from Johns Hopkins University describes recruitment for a study evaluating optical coherence tomography angiograp…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Heat Therapy in Older Hypertensive Women [NA]
The University of Texas Southwestern Medical Center completed a clinical trial evaluating heat therapy in older women with essential hyperte…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA. [Phase 3]
A Phase III randomized, active-controlled trial evaluating the efficacy and safety of nifedipine extended-release 30 mg in adults with mild …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension. [EARLY_Phase 1]
A Phase 1 trial evaluating the effects of antihypertensive treatment on brain blood flow, cognition, and nervous system regulation in older …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Mat Pilates With Paced Breathing Versus Diaphragmatic Breathing in Stage II Hypertension [NA]
A completed trial comparing mat Pilates with paced breathing versus diaphragmatic breathing in adults with Stage II hypertension to assess d…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription [NA]
A clinical trial entry describing the REMIDEP-HTA program aimed at hypertension remission and medication deprescription for essential hypert…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions [Phase 1]
This ClinicalTrials.gov entry outlines a Phase 1 pharmacokinetics and safety study of BR1015-A given alone and BR1015-1 with BR1015-2 under …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions [Phase 1]
A Phase 1 pharmacokinetics and safety study is evaluating BR1015-A and the co-administration of BR1015-1 with BR1015-2 under fed conditions …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions [Phase 1]
A Phase 1 clinical trial update from Boryung Pharmaceutical evaluating the pharmacokinetics and safety of BR1015-A alone and BR1015-3 with B…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions [Phase 1]
Phase 1 pharmacokinetic and safety study evaluating BR1015-A alone and co-administered BR1015-3 and BR1015-2 under fasting conditions in ess…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of TEL/AML/CTD in elderly patients with essential hypertension; the study is curre…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects [Phase 1]
Phase 1 trial update for SGB-3908 in healthy subjects and individuals with essential hypertension has completed.